UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2011-06, Vol.29 (16), p.2259-2265

2011

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Journal of clinical oncology, 2019-07, Vol.37 (21), p.1810-1818

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4649-4655

2009

Link zum Volltext

Verfügbarkeit prüfen

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents

The oncologist (Dayton, Ohio), 2010-10, Vol.15 (10), p.1026-1033

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Journal of clinical oncology, 2016-09, Vol.34 (25), p.3062-3068

2016

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4626-4633

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2811-2818

2007

Link zum Volltext

Verfügbarkeit prüfen

Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial

Gynecologic oncology, 2015-10, Vol.139 (1), p.70-76

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

Gynecologic oncology, 2011-09, Vol.122 (3), p.495-500

2011

Link zum Volltext

Verfügbarkeit prüfen

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial

JNCI : Journal of the National Cancer Institute, 2015-09, Vol.107 (9), p.1

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3104-3108

2009

Link zum Volltext

Verfügbarkeit prüfen

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group study

Gynecologic oncology, 2007-07, Vol.106 (1), p.16-22

2007

Link zum Volltext

Verfügbarkeit prüfen

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-12, Vol.127 (3), p.538-543

2012

Link zum Volltext

Verfügbarkeit prüfen

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control

American journal of obstetrics and gynecology, 2011-12, Vol.205 (6), p.509-510

McMeekin, D. Scott, MD

2011

Link zum Volltext

Verfügbarkeit prüfen

Ultra‐early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer

Cancer, 2010-02, Vol.116 (4), p.903-912

2010

Link zum Volltext

Verfügbarkeit prüfen

Vulvar cancer in young women: demographic features and outcome evaluation

American journal of obstetrics and gynecology, 2009-06, Vol.200 (6), p.645.e1-645.e5

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Gynecologic Oncology

9th edition., 2017

Link zum Volltext

Verfügbarkeit prüfen

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Gynecologic oncology, 2019-08, Vol.154 (2), p.294-301

2019

Link zum Volltext

Verfügbarkeit prüfen

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Gynecologic oncology, 2009-01, Vol.112 (1), p.40-46

2009

Link zum Volltext

Verfügbarkeit prüfen

Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis

Gynecologic oncology, 2009-02, Vol.112 (2), p.337-341

2009

Link zum Volltext

Verfügbarkeit prüfen

Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trial

Gynecologic oncology, 2013-05, Vol.129 (2), p.277-284

2013

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Gynecologic oncology, 2008-08, Vol.110 (2), p.133-139

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2010-01, Vol.116 (1), p.15-20

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma

Obstetrics and gynecology (New York. 1953), 2007-05, Vol.109 (5), p.1062-1067

2007

Link zum Volltext

Verfügbarkeit prüfen

Designing the next lymphadenectomy trial: What should we learn for our prior experiences

Gynecologic oncology, 2012-07, Vol.126 (1), p.1-2

McMeekin, D. Scott

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 187

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(96)
Female
(95)
Science & Technology
(95)
Life Sciences & Biomedicine
(92)
Oncology
(81)
Obstetrics And Gynecology
(76)
Middle Aged
(70)
Obstetrics & Gynecology
(65)
Aged
(62)
Adult
(54)
Hematology, Oncology And Palliative Medicine
(42)
Aged, 80 And Over
(41)
Gynaecology & Obstetrics
(34)
Neoplasm Staging
(33)
Biological And Medical Sciences
(29)
Medical Sciences
(28)
Retrospective Studies
(27)
Tumors
(26)
Disease-Free Survival
(22)
Endometrial Neoplasms - Pathology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II Trial of Bevacizumab in Recurrent or Persistent Endometrial Cancer: A Gynecologic Oncology Group Study

Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer

Phase III Trial of Four Cisplatin-Containing Doublet Combinations in Stage IVB, Recurrent, or Persistent Cervical Carcinoma: A Gynecologic Oncology Group Study

Endometrial Carcinoma: A Review of Chemotherapy, Drug Resistance, and the Search for New Agents

Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study

Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial

Phase II Trial of Ixabepilone As Second-Line Treatment in Advanced Endometrial Cancer: Gynecologic Oncology Group Trial 129-P

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: A Gynecologic Oncology Group study

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control

Ultra‐early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer

Vulvar cancer in young women: demographic features and outcome evaluation

Clinical Gynecologic Oncology

A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Stage IVB endometrial cancer: Does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis

Etiologic heterogeneity in endometrial cancer: Evidence from a Gynecologic Oncology Group trial

Ovarian cancer in the octogenarian: Does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Clinical and Pathologic Correlates in Surgical Stage II Endometrial Carcinoma

Designing the next lymphadenectomy trial: What should we learn for our prior experiences

Suchergebnisse filtern